USA —Abbott Laboratories, Inc. has concluded its acquisition of Bigfoot Biomedical—an innovative force in intelligent insulin management systems. While financial specifics remain undisclosed, the implications of this union are profound.…
Read MoreTag: Diabetes
Aspen Pharmacare and Novo Nordisk pioneer local insulin production in Africa to tackle diabetes crisis
SOUTH AFRICA — Africa’s leading pharmaceutical company, Aspen Pharmacare, has entered into a groundbreaking agreement with Danish healthcare firm Novo Nordisk to establish South Africa’s first production facility for human…
Read MoreNICE recommends Eli Lilly’s Mounjaro for treating type 2 diabetes in a turnaround decision
UNITED KINGDOM — In a surprising turn of events, the National Institute for Health and Care Excellence (NICE) has issued final draft guidance endorsing Eli Lilly’s Mounjaro (tirzepatide) as a…
Read MoreNovo’s Wegovy proves beneficial for individuals with obesity and heart failure
DENMARK — Novo Nordisk, the Danish pharmaceutical giant, has once again seized the spotlight with groundbreaking revelations about its weight loss drug, Wegovy. Following its recent revelation that Wegovy can…
Read MoreAmazon’s pioneering move aims at reinventing access to insulin and diabetes care
USA — In a pioneering stride aimed at transforming access to vital diabetes care, Amazon has introduced a remarkable expansion of its online pharmacy offerings, ensuring affordability and comprehensive support…
Read MoreRAK Hospital reiterates its support for diabetes management with a 3-month health challenge
UAE – RAK Hospital is rolling out a 3-month-long health challenge, titled RAK Diabetes Challenge 2023, to increase the engagement of residents in the management of diabetes. RAK Hospital, in…
Read MoreDr. Reddy’s Laboratories Ltd. launches new diabetes drug combination in the United States
INDIA – Dr. Reddy’s Laboratories Limited has introduced a new combination product for the treatment of type 2 diabetes in the United States. In a press statement, Dr. Reddy’s Laboratories…
Read MoreNovo Nordisk ramps up projections for obesity and diabetes drugs amidst cardiovascular breakthrough
DENMARK — Novo Nordisk, a pioneering force in diabetes and obesity treatments, is boldly elevating its forecasts following groundbreaking results showcasing the cardiovascular benefits of its drug Wegovy. In a…
Read MoreEli Lilly’s annual projections skyrocket amid surging demand for diabetes drug Mounjaro, propelling stock to record 18% surge
USA — Eli Lilly has experienced a big jump in its yearly predictions, driven by the growing demand for its new diabetes medication, Mounjaro. The hope that it might be…
Read MoreWegovy’s heart benefits shine in Novo Nordisk trial, reducing risk of problems
DENMARK —Novo Nordisk has released groundbreaking data from a major trial that showcases Wegovy’s remarkable ability to reduce the risk of “adverse cardiovascular events” by a substantial 20%. The company’s…
Read More